Combining two different immunotherapy treatments could dramatically improve lymphoma survival, according to a University of Southampton study.
Funded by Cancer Research UK and published in Cancer Cell the study tested different combinations of antibodies* in the lab to see how they interact with each other and what effect this has on how the immune system fights cancer.
